Massive european study to monitor common colds and flu in real time

NCT ID NCT06282718

Recruiting now Knowledge-focused Sponsor: European Clinical Research Alliance for Infectious Diseases (ECRAID) Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will follow 2,000 people of all ages who visit their doctor with symptoms of an acute respiratory infection, like cough, sore throat, or runny nose. Researchers will collect information on symptoms, treatments, and lab results to better understand how these infections spread and are managed across Europe. The goal is to build a research network that can quickly launch future studies on new treatments, tests, and vaccines.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study will provide crucial data on how respiratory infections present and are managed in community care, and create a ready-to-use network for future research on treatments, diagnostics, and prevention.
What could go wrong: This is an observational study, not testing any new treatment. It may face challenges in recruitment or data completeness, and results may not apply to all regions or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

respiratory tract infectious disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE RESPIRATORY TRACT INFECTION

Contacts and locations

Locations

Centre Hospitalier Universitaire de Limoges
RECRUITING

Limoges, France
Universiteit Antwerpen
RECRUITING

Antwerp, Belgium
University of Oxford
RECRUITING

Oxford, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.